Authors

• Nian Lu (ORCID: https://orcid.org/0000-0001-8001-3220)
• Xuguang Wang (ORCID: https://orcid.org/0000-0001-9181-6045)
• Ying Huang (ORCID: https://orcid.org/0000-0003-2420-5337)
• Yan‐Fang Ye (ORCID: https://orcid.org/0000-0002-5800-8377)
• Wei-Xin Bei (ORCID: https://orcid.org/0009-0000-8726-3134)
• Shuiqing He (ORCID: https://orcid.org/0000-0002-8873-0061)
• Liang‐Ru Ke (ORCID: https://orcid.org/0000-0001-7927-9726)
• Wei‐Xiong Xia (ORCID: https://orcid.org/0000-0002-2828-5963)
• Shu-Hui Dong
• Yan‐Qun Xiang (ORCID: https://orcid.org/0000-0003-4334-3794)
• Chong Zhao (ORCID: https://orcid.org/0000-0003-3271-5783)
• Chenao Zhang (ORCID: https://orcid.org/0009-0003-2370-0210)
• Cheng Xu (ORCID: https://orcid.org/0000-0002-4503-6029)
• Lin Wang (ORCID: https://orcid.org/0000-0002-9132-0805)
• Qin Liu (ORCID: https://orcid.org/0000-0001-9964-580X)
• Yaofei Jiang (ORCID: https://orcid.org/0000-0003-3825-8288)
• Hu Liang
• Guoying Liu

Institutions

• Nanchang University (CN)
• Sun Yat-sen University (CN)
• Sun Yat-sen Memorial Hospital (CN)
• Sun Yat-sen University Cancer Center (CN)
• First Affiliated Hospital of Nanchang University (CN)

Publication Details

Journal

BMC Medicine

Published

2025-03-11

DOI

https://doi.org/10.1186/s12916-025-03985-4

Citations

7

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

7.32

Funders

• National Natural Science Foundation of China